-
-
3，5-dimethoxy-(S)-4-
phenyl-BNO-PYBOX,97%, 25mg
-
di(pentan-3-yl)-(S)-4-benzyl PHO-PYBOX,97%, 25mg
-
VX809,10mM in DMSO, 1ml
-
1aH-Dibenzo[b，f]oxireno[2，3-d]azepine-6(10bH)-carboxamide,Analytical reference substance, ≥98% (HPLC), 5mg
-
1aH-Dibenzo[b，f]oxireno[2，3-d]azepine-6(10bH)-carboxamide,Analytical reference substance, ≥98% (HPLC), 25mg
-
Imidazo[1，2-f]phenanthridine,95%, 250mg
-
(12a，18a)-5，6，12，12a，13，18，18a，19-Octahydro-5，6-dimethyl-13，18[1’，2′]-benzenobisbenzimidazo [1，2-b:2’，1′-d]benzo[i][2.5]benzodiazocine potassium trifl,≥95%, 500mg
-
3-(Pyridin-2-yl)-2H-chromen-2-one,95%, 250mg
-
3-(2，6-Diisopropyl
phenyl)-5，6，7，8-tetrahydro-4H-cyclohepta[d]thiazol-3-ium perchlorate,98%, 100mg
-
(S)-1-(2，6-Diethyl
phenyl)-3-(1-hydroxy-3，3-dimethylbutan-2-yl)-4，5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V),98%, 100mg
-
(S)-1-(2，6-Diisopropyl
phenyl)-3-(1-hydroxy-3-methylbutan-2-yl)-4，5-dihydro-1H-imidazol-3-ium hexafluorophosphate(V),97%, 100mg
стр.: